On Wednesday, Telesta Therapeutics (Telesta Therapeutics Stock Quote, Chart, News: TSX:TST) announced it had entered into a licensing agreement with … [Read more...] about Telesta Therapeutics has a date with FDA destiny
Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, Chart, News: TSX:VRX), Canada’s largest and most recognizable healthcare company, has … [Read more...] about Is Bill Ackman right about Valeant Pharmaceuticals?
Today, Tekmira began trading under its new name and new symbol, Arbutus Biopharma Corporation, "ABUS" on Nasdaq. This is one of the final steps in its … [Read more...] about Tekmira: Goodbye Old Friend
On Friday, in a somewhat ambiguous news release, Tekmira updated investors on the Phase II ebola study being run in Sierra Leone with its RNA … [Read more...] about What Does the Future Hold for Tekmira’s Ebola Program?
This morning, Quebec City-based Opsens (Opsens Stock Quote, Chart, News: TSXV:OPS) announced it had received FDA 510(k) clearance to market its … [Read more...] about A Regulatory Hat-Trick: Opsens OptoWire Cleared for Sale in Japan, Europe, and now U.S
I am a proud Manitoban, and not only do I cheer for the Jets, I cheer for all things Manitoba. I cut my life science teeth so-to-speak, as a drug … [Read more...] about Medicure is Persevering on the Prairies
It would be an understatement to say that specialty pharma companies have been popular among Canadian investors of late. A quick scan of the one-year … [Read more...] about Theratechnologies Is Reinventing Itself
Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News: TSX:ONC, Nasdaq:ONCY) yesterday announced it had received orphan drug designation … [Read more...] about Oncolytics Biotech and Orphan Drug Designations: Wash, Rinse, Repeat
This past Friday, the tape was telling investors that something was up at Prometic Life Sciences (Prometic Stock Quote, Chart, News: … [Read more...] about Prometic Life Sciences should have strong clinical news flow in 2015
This week, Quebec City based, TSO3 (TSX:TOS), announced a $10 million bought deal financing co-led by Desjardins and Canaccord. As I discussed in … [Read more...] about TSO3 Goes it Alone. But For How Long?